Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D005047 |
Etoposide |
EN2 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D012701 |
Serotonin |
EN2 protein affects the abundance of Serotonin | affects abundance | 16935268
|
D012701 |
Serotonin |
EN2 protein affects the abundance of Serotonin metabolite | affects abundance | 16935268
|
D007608 |
Kainic Acid |
EN2 protein affects the susceptibility to Kainic Acid | affects response to substance | 19186208
|
D007608 |
Kainic Acid |
Kainic Acid results in decreased expression of EN2 mRNA | decreases expression | 19186208
|
D008942 |
Mitoxantrone |
EN2 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of EN2 mRNA | increases expression | 18175754
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of EN2 mRNA | decreases expression | 16604517
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.87 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.25 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.32 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.42 | 16456186 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 16935268 20523082 19186208 15024396 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
3.44 | 8570775 18361446 15132762 17157402 18062943 18405062 19221690 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.78 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.93 | 16197459 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.68 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
5.94 | 8112388 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.46 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.46 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.05 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.68 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.91 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.36 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.26 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.05 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
4.26 | 21254450 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.68 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
7.21 | 17157402 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.78 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.12 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 17551590 8800419 16925845 9142499 10589399 9211117 14991402 9125849 9664655 9224671 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
5.14 | 11488427 10446763 8112388 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.35 | 15131321 |
MESH:D004487 |
Edema |
|
Serotonin |
4.79 | 18841975 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.99 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.30 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.81 | 16938888 9664655 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.93 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.19 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.38 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.68 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.04 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.36 | 16019553 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
5.02 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
4.15 | 16135485 18180244 16200630 17606976 15147373 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.46 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.99 | 16778211 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.18 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.23 | 17551590 15992940 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.90 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.90 | 18172266 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.02 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.34 | 19075265 17506722 19642359 16331271 17339181 17368321 17107899 15748426 16788101 16766008 17361223 17217047 16891316 17712046 19035177 12679006 17294898 9834237 17301526 16140955 16935935 19225113 17649720 16823087 19029980 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.53 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 18397230 16248980 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
4.14 | 12556972 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.88 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.84 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.24 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
5.91 | 16640825 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.91 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.24 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.16 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
5.87 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.87 | 15976015 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.54 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.54 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.95 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.26 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.45 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
5.09 | 14601052 |
MESH:D012640 |
Seizures |
|
Kainic Acid |
4.57 | 18657176 10686065 19186208 17827730 19414003 14637104 15686955 16336964 1641125 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.73 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Kainic Acid |
6.16 | 19414003 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.26 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.09 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.41 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.98 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.13 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.44 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.25 | 16287080 |